Kura Oncology Q3 operating expenses USD 97.497 million
KURA•Kura Oncology reported Q3 operating expenses of USD 97.497 million and net income of USD -70.215 million.
1. Q3 results
Kura Oncology reported Q3 net income of USD -70.215 million.
KURA•Kura Oncology reported Q3 operating expenses of USD 97.497 million and net income of USD -70.215 million.
Kura Oncology reported Q3 net income of USD -70.215 million.